Antipicornavirus activity of SCH 47802 and analogs: In vitro and in vivo studies

Antiviral Research

Volumn 32, Issue 2, 1996, Pages 71-79

  Cox, Stuart ^a   Buontempo, Peter J ^a   Wright Minogue, Jacquelyn ^a   DeMartino, Jason L ^a   Skelton, Angela M ^a   Ferrari, Eric ^a   Schwartz, Jerome ^a   Rozhon, Edward J ^b   Linn, Chin Chung ^a   Girijavallabhan, V ^a   O'Connell, John F ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Shaman Pharmaceuticals Inc   (United States)

Author keywords

Antiviral agent; Enteroviruses; Picornaviruses; SCH 47802

Indexed keywords

1,4 BIS[(2 CHLORO 4 METHOXYPHENOXY)METHYL]BENZENE; ANTIVIRUS AGENT; PLACEBO; SCH 47802; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENCEPHALITIS; ENTEROVIRUS; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS INFECTION;

ANIMALIA; ENTEROVIRUS; MIRIDAE; MURINAE; POLIOVIRUS;

EID: 0030270640     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00979-5     Document Type: Article

References (50)

1. Alacron, B., Zerial., A., Dupiol, C. and Carrasco, L. (1986) Antirhinovirus compound 44 081 R.P. inhibits virus uncoating. Antimicrob. Agents Chemother. 30, 31-34.
2. Al-Nakib, W., Higgins, P.G., Barrow, G.I., Tyrrell, D.A.J., Andries, K., Vanden Bussche, G., Taylor, N. and Janssen, P.A.J. (1989) Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob. Agents Chemother. 33, 522-525.
3. Andries, K., Dewindt, B., De Brabander, M., Stokbroekx, R. and Janssen, P.A.J. (1988) In vitro activity of R61837, a new rhinovirus compound. Arch. Virol. 101, 155-167.
4. Andries, K., Dewindt, B., Snoeks, J. and Willebrords, R. (1989) Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization. Virology 106, 51-61.
5. Andries, K., Dewindt, B., Snoeks, J., Wouthers, L., Moereels, H., Lewi, P.J. and Janssen, P.A.J. (1990) Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J. Virol. 64, 1117-1123.
6. Andries, K., DeWindt, B., Snoeks, J, Willebrords, R., Van Eemeren, K., Stokbroekx, R. and Janssen, P.A.J. (1992) In vitro activity of pirodavir (R77975), a substituted phenoxypyridazinamine with broad-spectrum antipicornaviral activity. Antimicrob. Agents Chemother. 36, 100-107.
7. Badger, J., Minor, I., Kremer, M.J., Oliveira, M.A., Smith, T.J., Griffith, J.P, Guerin, D.M.A., Krishnaswamy, S., Luo, M., Rossmann, M.G., McKinlay, M.A., Diana, G.D., Dutko, F.J., Fancher, M., Rueckert, R.R. and Heinz, B.A. (1988) Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. Proc. Natl. Acad. Sci. USA 85, 3304-3308.
8. Barrow, G.I., Higgins, P.G., Tyrrell, D.A.J. and Andries, K. (1990) An appraisal of the efficacy of the antiviral R61837 in rhinovirus infections in human volunteers. Antiviral Chem. Chemother. 5, 279-283.
9. Chapman, M.S., Minor, I., Rossmann, M.G., Diana, G.D. and Andries, K. (1991) Human rhinovirus 14 complexed with antiviral compound R61837. J. Mol. Biol. 217, 455-463.
10. Dagan, R., Hall, C.B., Powell, K.R. and Menegus, M.A. (1989) Epidemiology and laboratory diagnosis of infection with viral and bacterial pathogens in infants hospitalized for suspected sepsis. Journal of Pediatrics (Sept.), 351-356.
11. Davies, O.L. and Goldsmith, P.L. (1972) Statistical Methods in Research and Production, pp. 317-323. Hafner Publishing Company, New York.
12. Diana, G.D., McKinlay, M.A., Brisson, C.J., Zalay, E.S., Miralles, J.V. and Salvador, U.J. (1985) Isoxazoles with antipicornavirus activity. J. Med. Chem. 28, 748-752.
13. Eggers, H.J. (1985) Antiviral agents against picornaviruses. Antiviral Res. (Suppl. 1), 57-65.
14. Eggers, H.J., Koch, M.A., Furst, A., Daves, Jr., G.D., Wilczynski, J.J. and Folkers, K. (1970) Rhodanine: a selective inhibitor of the multiplication of echovirus 12. Science 167, 294-297.
15. Fox, P.M., Otto, M.J. and McKinlay, M.A. (1986) Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. Antimicrob. Agents Chemother. 30, 110-116.
16. Girijavallabhan, V., Ganguly, A., Versace, R. (1995) US Patent No. 5350 772.
17. Greve, J.M., Davis, G., Meyer, A.M., Forte, C.P., Yost, S.C., Marlor, C.W., Kamarck, M.E. and McClelland, A. (1989) The major human rhinovirus receptor is ICAM-1. Cell 56, 839-847.
18. Hayden, F.G., Andries, A. and Janssen, P.A.J. (1992) Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection. Antimicrob. Agents Chemother. 36, 727-732.
19. Heinz, B.A. (1990) Escape mutant analysis of a drug-binding site can be used to map functions in the rhinovirus capsid. In: W.G. Laver and G.M. Air (Eds.), Use of X-Ray Crystallography in the Design of Antiviral Agents, pp. 173-186. Academic Press, San Diego, CA.
20. Heinz, B.A., Rueckert, R.R., Shepard, D.A., Dutko, F.J., McKinlay, M.A., Fancher, M., Rossmann, M.G., Badger, J. and Smith, T.J. (1989) Genetic and molecular analysis of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J. Virol. 63, 2476-2485.
21. Higgins, P.G., Scott, P.J., Daniels, P.M. and Gamble, D.R. (1974) A comparative study of viruses associated with acute hemorrhagic conjunctivitis. J. Clin. Pathol. 27, 292-296.
22. Hogle, J.M., Chow, M. and Filman, D.J. (1985) Three-dimensional structure of poliovirus at 2.9 Å resolution. Science 229, 1358-1365.
23. Ishitsuka, H., Ohsawa, C., Ohiwa, T., Umeda, I. and Suhara, Y. (1982) Anti-picornavirus flavone Ro 09-0179. Antimicrob. Agents Chemother. 22, 611-616.
24. Jubelt, B., Ghislaine, G., Narayan, O. and Johnson, R.T. (1980). Pathogenesis of human poliovirus infection in mice. 1. Clinical and pathogenesis studies. J. Neuropathol. Exp. Neurol. 39, 138-148.
25. Kenny, M.T., Dulworth, J.K. and Torney, H.L. (1985) In vitro and in vivo antipicornavirus activity of some phenoxypyridine-carbonitriles. Antimicrob. Agents Chemother. 28, 745-750.
26. Kenny, M.T., Dulworth, J.K., Bargar, T.M. and Daniel, J.K. (1987) Antipicornavirus activity of some diaryl methanes and aralkylamino-pyridines. Antiviral Res. 7, 87-97.
27. McKinney, R.I., Katz, S.L. and Wilfert, C.M. (1987) Chronic enteroviral menigoencephalitis in agammaglobulin patients. Rev. Infect. Dis. 9, 334-356.
28. McSharry, J.J., Caliguiri, L.A. and Eggers, H.J. (1979) Inhibition of uncoating of poliovirus by arildone, a new antiviral drug. Virology 97, 307-315.
29. Modlin, J.F. (1990) Coxsackievirus, echovirus and newer enteroviruses. In: G.L. Mandell, R.G. Douglas, Jr. and J.E. Bennet (Eds), Principles and Practice of Infectious Disease, pp. 1367-1383. Churchill Livingstone, New York.
30. Mossmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
31. O'Connell, J.F., Albin, R., Blum, D., Grint, P. and Schwartz, J. (1995) Development of antiviral agents for picornavirus infections. In: H.A. Rotbart (Ed), Human Enterovirus Infections, pp. 419-434. American Society for Microbiology, Washington, D.C..
32. Otto, M.J., Fox, M.P., Fancher, M.J., Kuhrt, M.F., Diana, G.D. and McKinlay, M.A. (1985) In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug. Antimicrob. Agents Chemother. 27, 883-886.
33. Rossmann, M.G. (1989) The structure of antiviral agents that inhibit uncoating when complexed with viral capsids. Antiviral Res. 11, 3-14.
34. Rossmann, M.G., Arnold, E., Erickson, E.A., Frankenberger, E.A., Griffith, J.P., Hecht, H.-J., Johnson, J.E. and Kamer, G. (1985) Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317, 145-153.
35. Rotbart, H.A. (1989) Human enterovirus infections: molecular approaches to diagnosis and pathogenesis. In: B.L. Semler and E. Ehrenfeld (Eds), Molecular Aspects of Picornavirus Infection and Detection, pp. 243-264. American Society for Microbiology, Washington, D.C..
36. Rozhon, E., Cox, S., Buontempo, P., O'Connell. J., Slater, W., DeMartino, J., Schwartz, J., Miller, G., Arnold, E., Zhang, A., Morrow, C., Jablonski, S., Pinto, P., Verace, R., Duelfer, T. and Girijavallabhan, V. (1993) SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating. Antiviral Res. 21, 15-35.
37. Rueckert, R.R. (1990) Picornaviridae and their replication. In: B.N. Fields and D.M. Knipe (Eds), Virology, pp. 507-548. Raven Press, New York.
38. Rueckert, R.R. and Pallansch, M.A. (1981) Preparation and characterization of encephalomyocarditis virus. Methods Enzymol. 78, 315-325.
39. Schiff, G.M., Sherwood, J.R., Young, B.C. and Mason, L.J. (1992) Prophylactic efficacy of WIN 54954 in prevention of experimental human coxsackievirus A21 infection and illness. Antiviral Res. 17 (Suppl. 1), 92.
40. Smith, T.J., Kremer, M.J., Luo, M., Vriend, G., Arnold, E., Kamer, G., Rossmann, M.G., McKinlay, M.A., Diana, G.D. and Otto, M.J. (1986) The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233, 1286-1293.
41. Staunton, D.E., Merluzzi, V.J., Rothlein, R., Barton, R., Marlin, S.D. and Springer, T.A. (1989) A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56, 849-853.
42. Strikas, R.A., Anderson, L.J. and Parker, R.A. (1986) Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J. Infect. Dis. 153, 346-351.
43. Tomassini, J.E., Graham, D., DeWitt, C.M., Lineberger, D.W., Rodkey, J.A. and Colonno, R.J. (1989) cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 86, 4907-4911.
44. Trousdale, M.D., Paque, R.E. and Gauntt, C.J. (1977) Isolation of coxsackievirus B3 temperature sensitive mutants and their assignment to complementation groups. Biochem. Biophys. Res. Commun. 76, 368-375.
45. Turner, R.B., Dutko, F.J., Golstein, N.H., Lockwood, G. and Hayden, F.G. (1993) Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection. Antimicrob. Agents Chemother. 37, 297-300.
46. Woods, M.G., Diana, G.D., Rogge, M.C., Otto, M.J., Dutko, F.J. and McKinlay, M.A. (1989) In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob. Agents Chemother. 33, 2069-2074.
47. Yin-Murphy, M. (1984) Acute hemorrhagic conjunctivitis. Prog. Med. Virol. 29, 43-44.
48. Zeichardt, H., Otto, M.J., McKinlay, M.A., Willingmann, P. and Habermehl, K.-O. (1987) Inhibition of poliovirus uncoating by disoxaril (WIN 51711). Virology 160, 281-285.
49. Zhang, A., Nanni, R.G., Arnold, G.F., Oren, D.A., Li, T., Jacobo-Molina, A., Williams, R.L., Kamer, G., Rubenstein, D.A., Li, Y., Rozhon, E.J., Cox, S., Buontempo, P., O'Connell, J., Schwartz, J., Miller, G., Nash, C., Bauer, B., Versace, R., Ganguly, A., Girijavallabhan, V. and Arnold, E. (1991) Structure of a complex of human rhinovirus 14 with a water soluble antiviral compound SCH 38057. J. Mol. Biol. 230, 857-867.
50. Zhang, A., Nanni, R.G., Oren, D.A., Rozhon, E.J. and Arnold, E. (1992) Three-dimensional structure-activity relationships for antiviral agents that interact with picornavirus capsids. Semin. Virol. 3, 453-471.